Author/Authors :
Nafar, Mohsen Division of Nephrology - Department of Internal Medicine - Shahid Labbafinejad Medical Center & Urology and Nephrology Research Center - Shaheed Beheshti Medical University, Tehran, Iran , Mousavi, Mohsen Department of Community Medicine - Cancer Research Center of Cancer Institute - Tehran University of Medical Sciences, Tehran, Iran , Mahdavi, Mitra Division of Nephrology - Department of Internal Medicine - Imam Khomeini Hospital - Tehran University of Medical Sciences, Tehran, Iran , Pour Reza Gholi, Fatemeh Division of Nephrology - Department of Internal Medicine - Shahid Labbafinejad Medical Center & Urology and Nephrology Research Center - Shaheed Beheshti Medical University, Tehran, Iran , Firoozan, Ahmad Division of Nephrology - Department of Internal Medicine - Shahid Labbafinejad Medical Center & Urology and Nephrology Research Center - Shaheed Beheshti Medical University, Tehran, Iran , Einollahi, Behzad Division of Nephrology - Department of Internal Medicine - Baqyiatollah University of Health and Medical Services, Tehran, Iran , Lessan Pezeshki, Mahboob Division of Nephrology, Department of Internal Medicine - Imam Khomeini Hospital - Tehran University of Medical Sciences, Tehran, Iran , Asbaghi Namini, Somayeh Division of Nephrology - Department of Internal Medicine - Shahid Labbafinejad Medical Center & Urology and Nephrology Research Center - Shaheed Beheshti Medical University, Tehran, Iran , Farrokhi, Farhat Division of Nephrology - Department of Internal Medicine - Shahid Labbafinejad Medical Center & Urology and Nephrology Research Center - Shaheed Beheshti Medical University, Tehran, Iran
Abstract :
Introduction. The latent nature of chronic kidney disease (CKD) in
primary stages precludes early diagnosis. This necessitates plans
such as screening, but we should first introduce CKD as a public
health problem. This study was designed to define the burden of
CKD in Iran.
Materials and Methods. We calculated disability-adjusted life years
(DALYs) according to the World Health Organization’s practical
guidelines for national burden of disease studies. The sum of
years of life lost and years lived with disability were estimated
for CKD stages 1 to 4 and end-stage renal disease (ESRD) based
on the national registry data and the published reports about CKD
in Iran in 2004.
Results. Over 700 000 people were estimated to have CKD in
Iran in 2004 and 61 000 new cases of CKD were anticipated. The
prevalence rate of CKD was estimated to be 1083 and its incidence
rate was 173.5 per 100 000 population. Chronic kidney disease was
responsible for 1 145 654 DALYs. The highest DALYs for stages
1 to 4 of CKD were due to unknown etiology, diabetes mellitus,
and hypertension (382 000 years, 347 400 years, and 311 800 years,
respectively). The DALY for ESRD and CKD stages 1 to 4 were 21
490 years and 1 124 164 years, respectively.
Conclusions. The present study provides an estimate of the burden
of CKD in Iran. As CKD can be controlled by practical cost-effective
plans, we strongly recommend the information given by this study
be considered for future action plans.
Keywords :
chronic kidney disease , prevalence , adjusted life years , mortality , Iran
